Font Size: a A A
Keyword [Papillary Thyroid Cancer]
Result: 41 - 60 | Page: 3 of 10
41. Expression Of Galectin-3and MMP-2in Thyroid Cancer And Their Clinical Significances
42. Ultrasound Contrast Marking And Papillary Thyroid Cancer Genetics
43. The Expression Of MiR-124and The Mechanism Of MiR-124in Suppressing Tumor Proliferation, Invasion And Metastasis By Targeting IQGAP1in Thyroid Papillary Cancer
44. Investigating For The Clinical And Pathological Features Of Papillary Thyroid Cancer Coexistent With Hashimoto’s Thyroiditis
45. Association Between ATM Gene Polymorphism And Susceptibility To Thyroid Cancer
46. The Clinical Value Of Serum MicroRNAs Expression In Papillary Thyroid Cancer
47. MiR-146b-5p In Papillary Thyroid Cancer In TPC-1
48. Surgical Treatment For Primary Papillary Thyroid Cancer: A Meta-analysis
49. The Expression And Clinical Significance Of TRα1 From Papillary Thyroid Carcinoma And Nodular Goiter
50. Gender-related Clinical Characteristics And Sensitive Gene Expression Analysis In Patients With Differentiated Thyroid Cancers
51. Expressions And Biological Significance Of Immune Cells In Hashimoto’s Thyroiditis Complicated With Papillary Throid Carcinoma
52. The Expression Level Of ER In Papillary Thyroid Cancer And Its Clinical Significance
53. 70 Cases Of Clinical Analysis Of Surgical Treatment Of Papillary Thyroid Carcinoma
54. Replication And Meta-Analysis Of Common Gene Mutations In TTF1 And TTF2 With Papillary Thyroid Cancer
55. Study Of The Relationship Between Serum Thyroglobulin And Metastases As Well As The Treatment Response In Patients With Differentiated Thyroid Carcinoma
56. 17Beta-estradiol Mediated Expression Of Hsp27 In Papillary Thyroid Cancer And Its Molecular Mechanism
57. Identification Of Specific Long Non-Coding RNA Expression:Profile And Analysis Of Association With Clinicopathoiogical Characteristics And BRAF-mutation In Papillary Thyroid Cancer
58. Differentiation Between Malignant And Benign Thyroid Nodules And Stratification Of Papillary Thyroid Cancer With Aggressive Histological Features Using The Reduced Field Of View DWI
59. Association Of BRAF T1799A Mutation With TGF-? And Its Effect On The Prognosis Of Patients With Papillary Thyroid Cancer
60. I. Cell Cycle Detection Point Kinase 2 (CHK2) Regulates The Malignant Phenotype And Mechanism Of Papillary Thyroid Carcinoma II. Preliminary Screening Of Differentially Expressed LncRNA/mRNA In Human Thyroid Papillary Carcinoma Resistant To Anoikis
  <<First  <Prev  Next>  Last>>  Jump to